Summary: In Dr. Bronner’s All-One! Blog, David Bronner and Les Szabo outline the numerous challenges of increasing access to psychedelics amidst a profit-driven economic system, and explain their company’s philanthropic support of MAPS’ non-profit approach.
“As we envision the future of the industry we want to see,” they suggest, “we must first consider who—and what—exactly we are trying to heal with psychedelic medicine.”
Originally appearing here.
